Cite
HARVARD Citation
Shiffman, M. et al. (n.d.). Efficacy of Ombitasvir/Paritaprevir/ and Dasabuvir +/‐Ribavirin in Patients Receiving Concomitant Acid‐Reducing Agents in Phase 3 Trials. American journal of gastroenterology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shiffman, M. et al. (n.d.). Efficacy of Ombitasvir/Paritaprevir/ and Dasabuvir +/‐Ribavirin in Patients Receiving Concomitant Acid‐Reducing Agents in Phase 3 Trials. American journal of gastroenterology. p. . [Online].